D&D Pharmatech is a Health care Company.
D&D Pharmatech is a operator of a holding company created to fund the development of therapeutic medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. The company's product pipeline focuses on a range of indications including neurodegenerative, metabolic and fibrotic diseases, providing the opportunity to accelerate the translation of cutting-edge research into lifesaving therapeutic products for patients.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 19, 2021 | Series C | $51M | 1 | — | — | Detail |
Jan 1, 2018 | Series A | $36M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Korea Investment Securities | — | Series C |
Geon Investment | — | Series A |